David, Bastian
Eberle, Jasmine
Delev, Daniel
Gaubatz, Jennifer
Prillwitz, Conrad C.
Wagner, Jan
Schoene-Bake, Jan-Christoph
Luechters, Guido
Radbruch, Alexander
Wabbels, Bettina
Schramm, Johannes
Weber, Bernd
Surges, Rainer
Elger, Christian E.
RĂ¼ber, Theodor
Funding for this research was provided by:
Projekt DEAL
Article History
Received: 26 September 2020
Accepted: 24 December 2020
First Online: 14 January 2021
Competing interests
: JW received fees as speaker or consultant from Eisai, Bial and UCB. AR lectures for Guerbet and Bayer. He receives institutional study support by Guerbet and Bayer. CE reports personal fees from UCB, Desitin, BIAL, and Eisai. CE was Medical Director for the Life & Brain institute until 2015 and also served as Platform Leader for Cognitive Neuroscience until 2017. RS has received fees as speaker or consultant from Bial, Cyberonics, Desitin, Eisai, LivaNova, Novartis, and UCB Pharma. The remaining authors have no conflict of interest.